Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2025 | Prehabilitation and rehabilitation to optimise function during CAR-T

In this video, Orla McCourt, MSc, MCSP, University College London NHS Foundation Trust, London, UK, briefly discusses the potential of implementing prehabilitation and rehabilitation to optimize function during CAR T-cell therapy. Although the current evidence to support this is limited, the existing strong evidence base for exercise and rehabilitation in the stem cell transplantation setting may apply to CAR-T. This interview took place at the EHA-EBMT 7th European CAR T-cell Meeting, held in Strasbourg, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript (AI-generated)

So I gave a talk today as part of the Nursing and Allied Health Professionals session on prehabilitation and rehabilitation for CAR-T. And really the basis of my talk was talking about how the current evidence within CAR-T is quite limited in it being a newly implemented therapy, but that we have quite significant and strong evidence now for exercise and rehabilitation in the stem cell transplantation population and so there’s some opinion pieces and thoughts within the field about how we can use some of the conclusions and findings in our stem cell transplant population and literature to apply that to implementing programs within CAR-T...

So I gave a talk today as part of the Nursing and Allied Health Professionals session on prehabilitation and rehabilitation for CAR-T. And really the basis of my talk was talking about how the current evidence within CAR-T is quite limited in it being a newly implemented therapy, but that we have quite significant and strong evidence now for exercise and rehabilitation in the stem cell transplantation population and so there’s some opinion pieces and thoughts within the field about how we can use some of the conclusions and findings in our stem cell transplant population and literature to apply that to implementing programs within CAR-T.

 

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Disclosures

Education grant: Kite/Gilead; Honorarium: Menarini Stemline.